• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

2016 TVM Capital Life Science Autumn Conference

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

TVM Captal Autumn Conference 2016Thank you for for making our 5th annual TVM Capital Life Science Autumn Conference 2016 which took place on Monday, September 19th in Montreal, a great success!

Our annual invitation only conference was attended by approx. 200 international participants from Asia, the United States and Europe who join us to network with senior decision makers from biotech and pharmaceutical companies as well as Venture Capital and investor groups.

We were very honored to welcome Dominique Anglade, Minister of Economy, Science and Innovation who was introduced by Vanessa Grant, Norton Rose Fulbright and Mr. Darren J. Carroll, Senior Vice President Corporate Business Development, Eli Lilly and Company, as the Keynote Speaker of this year’s event. We would like to thank our sponsors and supporters for their trust and continued support and look forward to seeing our international peers again next year!

Agenda

11.30pmRegistration and light lunch
12.30pmSpecial Speaker:
Dominique Anglade, Minister of Economy, Science and Innovation
Introduction by Vanessa Grant, Norton Rose Fulbright
12.45pmWelcome Address
Luc Marengere, Managing Partner, TVM Capital Life Science
13.00pmKeynote Speaker:
Darren Carroll, Sr. Vice President, Corporate Business Development, Eli Lilly & Co
Moderator and introduction: Hubert Birner, Managing Partner, TVM Capital Life Science
1.45pmPanel #1: Immune Oncology – Opportunities and Challenges:
Wilson H. Miller, Jr., James McGill Professor in the Departments of Oncology and Medicine at McGill University
Mario Sznol, Professor of Internal Medicine at Yale University School of Medicine, Greg Plowman, Vice President, Lilly Oncology Research / Senior Vice President, Imclone Systems Research
Brian Stuglik, Founder, Proventus Health Solutions LLC
Moderator and introduction: Marc Rivière, General Partner, TVM Capital Life Science
2.45pmGary Muirhead, CEO of Ixchelsis Ltd.
Moderator and introduction: Luc Marengere, Managing Partner, TVM Capital Life Science
3.45pmCoffee Break
4.15pmPanel #2: Orphan Drugs & Rare Diseases - Outlook for 2020
Chris Schelling, Founder and CEO of Acer Therapeutics Inc.
André Turenne, Senior Vice President and Global Head of Business Development & Licensing at Sanofi
Marlene Haffner, Haffner Associates, LLC, Orphan Solutions
Alexandre Lebeaut, SVP and Head of Global Drug Development at Ipsen
Moderator: Cynthia Lavoie, General Partner, TVM Capital Life Science
5.15pmThomas P. Mathers, CEO of CoLucid Pharmaceuticals, Inc.
Moderator and introduction: Marc Rivière, General Partner, TVM Capital Life Science
6.00pmWrap up and Outlook
Hubert Birner, Managing Partner, TVM Capital Life Science
6.30pmEvening Reception at Hotel Omni Mont-Royal, Room “Printemps”
Platinum Sponsor
norton-rose-fulbright
Gold Sponsors
aird-berlisbanque-nationaleclark-elbingErnst & YoungfondsftqfoleyhoagiqRoyal Bank of Canada

2016 TVM Capital Life Science Autumn Conference

Date:
September 19, 2016
Venue:
Montreal

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact